BUSSOLARI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 220
EU - Europa 9
AS - Asia 5
AF - Africa 2
SA - Sud America 2
Totale 238
Nazione #
US - Stati Uniti d'America 218
IT - Italia 5
VN - Vietnam 4
DE - Germania 3
CA - Canada 2
CL - Cile 2
ZA - Sudafrica 2
CN - Cina 1
NL - Olanda 1
Totale 238
Città #
Fairfield 48
Ashburn 19
Woodbridge 19
Cambridge 18
Santa Cruz 16
Seattle 16
Wilmington 15
Houston 11
Ann Arbor 7
Buffalo 7
Dong Ket 4
Chicago 3
Las Vegas 2
Modena 2
Ottawa 2
Riva 2
San Diego 2
Santa Maria Di Sala 2
University Park 2
Atlanta 1
Beijing 1
Bloomfield 1
Büdelsdorf 1
Grafing 1
Henderson 1
Indianapolis 1
Leiden 1
Los Angeles 1
Mountain View 1
Muizenberg 1
Provo 1
San Jose 1
Silverton 1
Totale 211
Nome #
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility, file e31e124a-a079-987f-e053-3705fe0a095a 137
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells., file e31e124e-0faf-987f-e053-3705fe0a095a 95
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers., file e31e124b-b427-987f-e053-3705fe0a095a 9
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells, file e31e124a-9c3b-987f-e053-3705fe0a095a 3
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy, file e31e124a-a2d1-987f-e053-3705fe0a095a 2
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells, file e31e124a-ac99-987f-e053-3705fe0a095a 1
Totale 247
Categoria #
all - tutte 345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0000 05 58 11551
2020/2021106 45196 36 526 67109
2021/202280 145123 31 93 17175
2022/202318 12150 00 00 0000
Totale 247